-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. ROLE SUMMARY As a member of our NGS and Data Science team, you will
-
cutting edge design and process development capabilities to accelerate and bring the best-in-class medicines to patients around the world. What You Will Achieve Pfizer's BioMedicine Design (BMD) is seeking
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. ROLE SUMMARY As a member of our NGS and Data Science team, you will
-
experiment design. These goals will be achieved through partnership with other disciplines including data scientists, analytical chemists, engineers, and process chemists to develop digital and robotic
-
to support decision making in the drug development process. The General Toxicology R6 Study Director is responsible for the design, conduct, interpretation, and reporting of exploratory, mechanistic and GLP in
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve A Scientist (level R3) position is available
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve Drug Safety Research & Development (DSRD) is
-
collaborators to drive the design and execution of experiments and take a "hands on" role in laboratory activities. The incumbent will contribute to strategic directions for projects. The appointee will be part
-
cutting edge design and process development capabilities to accelerate and bring the best - in - class medicines to patients around the world. What You Will Achieve Designing new medicines at Pfizer
-
-leading team whose mission is to identify key risks associated with unwanted clinical immunogenicity and influence drug design to mitigate those risks. We are currently seeking an experienced immunogenicity